Please wait...
About This Project
OncoSynergy, Inc.
The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
Recent Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Lost in the mountains: Describing new species in the High Atlas Mountains of Morocco
Biodiversity is not evenly distributed on the planet, but is concentrated in hotspots, with high conservation...
The first look at pumas and reintroduced endangered wolves of northern México
Puma (Puma concolor) ecology in northern Mexico is essentially unknown and thus far, has relied on camera...
How Insects and Bacteria Can Solve Murder Mysteries
We study how communities of insects and bacteria inhabiting human cadavers change through time. This pattern...
